Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (241-250 of 418) with videos related to

Pageof 42
Sort By:
Cancers|January 11, 2022
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET StudySara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2012
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancerKatsuyuki Hotta, Etsuji Suzuki, Massimo Di Maio, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2009
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trialCarmela Pisano, Alessandro Morabito, Roberto Sorio, et al.
Clinical Colorectal Cancer|February 25, 2020
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802)Evaristo Maiello, Gabriele Di Maggio, Stefano Cordio, et al.
Oncotarget|January 20, 2018
Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysisCarmine De Angelis, Massimo Di Maio, Anna Crispo, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2015
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patientsSebastiano Buti, Paola Bordi, Marcello Tiseo, et al.
Recenti Progressi in Medicina|November 16, 2021
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]Claudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Emerging Microbes & Infections|May 13, 2024
Emergence of multidrug-resistant <i>Staphylococcus haemolyticus</i> in neonatal intensive care unit in Southern France, a genomic studyChloé Magnan, Madjid Morsli, Florian Salipante, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 18, 2016
Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the LungLuisella Righi, Simona Vatrano, Federica Di Nicolantonio, et al.
Tumori|April 1, 2022
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysisFabio Turco, Marcello Tucci, Tiziana Angusti, et al.
Pageof 42

Showing results (241-250 of 418) with videos related to

Sort By:
Pageof 42
Cancers|January 11, 2022
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET StudySara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2012
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancerKatsuyuki Hotta, Etsuji Suzuki, Massimo Di Maio, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2009
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trialCarmela Pisano, Alessandro Morabito, Roberto Sorio, et al.
Clinical Colorectal Cancer|February 25, 2020
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802)Evaristo Maiello, Gabriele Di Maggio, Stefano Cordio, et al.
Oncotarget|January 20, 2018
Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysisCarmine De Angelis, Massimo Di Maio, Anna Crispo, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2015
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patientsSebastiano Buti, Paola Bordi, Marcello Tiseo, et al.
Recenti Progressi in Medicina|November 16, 2021
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]Claudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Emerging Microbes & Infections|May 13, 2024
Emergence of multidrug-resistant <i>Staphylococcus haemolyticus</i> in neonatal intensive care unit in Southern France, a genomic studyChloé Magnan, Madjid Morsli, Florian Salipante, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 18, 2016
Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the LungLuisella Righi, Simona Vatrano, Federica Di Nicolantonio, et al.
Tumori|April 1, 2022
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysisFabio Turco, Marcello Tucci, Tiziana Angusti, et al.
Pageof 42